In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma

NCT03481231 · clinicaltrials.gov ↗
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Centre Georges Francois Leclerc